+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Bacterial Pneumonia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767627
  • Report
  • April 2019
  • Region: Global
  • 125 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Bacterial Pneumonia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Bacterial Pneumonia. It presents in-depth analysis of Bacterial Pneumonia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Bacterial Pneumonia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Bacterial Pneumonia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Bacterial Pneumonia

The research work is prepared through extensive and continuous research on Bacterial Pneumonia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Bacterial Pneumonia patients are identified
  • The report includes panorama of Bacterial Pneumonia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Bacterial Pneumonia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Bacterial Pneumonia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Bacterial Pneumonia Clinical Trials by Region
2.2.2 Average Enrollment of Bacterial Pneumonia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Bacterial Pneumonia Treatment, 2019

3. Region wise Bacterial Pneumonia Clinical Trials
3.1 Asia Pacific Bacterial Pneumonia Clinical Trials by Country
3.2 Europe Bacterial Pneumonia Clinical Trials by Country
3.3 North America Bacterial Pneumonia Clinical Trials by Country
3.4 Middle East and Africa Bacterial Pneumonia Clinical Trials by Country
3.5 South and Central America Bacterial Pneumonia Clinical Trials by Country

4. Bacterial Pneumonia Clinical Trial Trends
4.1 Start Year wise Bacterial Pneumonia Clinical Trials
4.2 Phase wise Bacterial Pneumonia Clinical Trials
4.3 Trial Status wise Bacterial Pneumonia Clinical Trials
4.4 Trial Type wise Bacterial Pneumonia Clinical Trials

5. Bacterial Pneumonia Average Enrollment Trends
5.1 Average Enrollment in Bacterial Pneumonia Trials by Year
5.2 Average Enrollment in Bacterial Pneumonia Trials by Phase
5.3 Average Enrollment in Bacterial Pneumonia Trials by Status
5.4 Average Enrollment in Bacterial Pneumonia Trials by Type of Trial

6. Companies Participating in Bacterial Pneumonia Clinical Trials
6.1 Bacterial Pneumonia Trials by Sponsor Type
6.2 Bacterial Pneumonia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Bacterial Pneumonia Trials- Phase 1
7.2 Bacterial Pneumonia Trials- Phase 2
7.3 Bacterial Pneumonia Trials- Phase 3
7.4 Bacterial Pneumonia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Bacterial Pneumonia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Figure 7: North America - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Figure 9: Bacterial Pneumonia Clinical Trials by Phase
Figure 10: Bacterial Pneumonia Clinical Trials by Trial Status
Figure 11: Bacterial Pneumonia Clinical Trials by Type
Figure 12: Bacterial Pneumonia Clinical Trials by Sponsor Type
Figure 13: Bacterial Pneumonia Clinical Trials by Leading Sponsors
Figure 14: Bacterial Pneumonia Average Enrollment by Phase
Figure 15: Bacterial Pneumonia Average Enrollment by Trial Status
Figure 16: Bacterial Pneumonia Average Enrollment by Type
Figure 17: Bacterial Pneumonia- Average Enrolment by Type of Sponsors
Figure 18: Bacterial Pneumonia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Bacterial Pneumonia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Table 5: Europe - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Table 7: North America - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Bacterial Pneumonia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Bacterial Pneumonia Average Enrollment by Phase
Table 15: Bacterial Pneumonia Average Enrollment by Trial Status
Table 16: Bacterial Pneumonia Average Enrollment by Type
Table 17: Bacterial Pneumonia- Average Enrolment by Type of Sponsors
Table 18: Bacterial Pneumonia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Allergan Plc
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Wockhardt Ltd
Note: Product cover images may vary from those shown
Adroll
adroll